(MENAFN- GlobeNewsWire - Nasdaq) U.S. Intravenous (IV) Solutions Market size was USD 3.91 Billion in 2025 and is expected to reach USD 8.39 Billion by 2035 owing to advanced healthcare infrastructure ...
Austin, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Intravenous (IV) Solutions Market Size & Growth Analysis: According to SNS Insider, the Intravenous (IV) Solutions Market size was valued at USD 13.35 ...
SAN CLEMENTE, Calif., Aug. 10, 2020 /PRNewswire/ -- ICU Medical Inc. (NASDAQ: ICUI) today announced that it has entered into a long-term agreement with Grifols to distribute a full line of non-PVC/non ...
Key growth drivers include rising surgical and procedural volumes, particularly in outpatient settings, increased use of IV therapy for managing chronic conditions such as cancer and renal disease, ...
ICU Medical (NASDAQ:ICUI) and Otsuka Pharmaceutical Factory, a unit of Japan’s Otsuka, are launching a joint venture focused on boosting IV solutions production and development in North America. The ...
(MENAFN- IMARC Group) Setting up IV solutions manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw ...
19Mar2007Abu Dhabi: The UAE Offsets Group said yesterday it would set up one of the region's largest manufacturing plants for intravenous (IV) solutions in Abu Dhabi.According to the group, the plant ...
Baxter announced that it is increasing manufacturing capacity at its other facilities and is able to increase current allocation levels. The impact of Hurricane Helene has led to a temporary supply ...
Hospitals across the U.S. are feeling the impact of Hurricane Helene as experts warn of an imminent intravenous (IV) solution shortage due to the temporary shutdown of a facility in a North Carolina.
Hurricane Helene shut down a top manufacturer of IV solutions in the U.S., threatening hospitals across the country with shortages. Milton’s landfall this week could make the problem even worse.
Baxter International Inc. on Monday issued a voluntary recall for select lots of two kinds of its intravenous solutions due to particulate matter found in the solutions. Baxter said the recall ...